Close
Nordic 9Nordic 9

Thairm Bio (investor - Others)

United Kingdom
See something wrong or missing? Let us know

Thairm Bio is a Scotland-based family office that invests in early-stage life science companies

Average round investment:12.03M USD
Average number per year:1.3
Distribution: 2024 (1)2023 (2)2021 (1)
Portfolio companies: United Kingdom PhloUnited Kingdom Microplate DxUnited Kingdom EnteroBiotix
Mostly invests in: United Kingdom United Kingdom (4) Pharma (3)
See the entire list

Showing 3 of 4 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Thairm Bio mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Thairm Bio

Name Criteria
United Kingdom Conduit Ventures
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Manufacturing, Health services
  • Similar business models: B2C (Retail), B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
France Fidji Simo
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Marketplace, Ecommerce, Manufacturing
  • Similar business models: B2C (Retail), B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
United Kingdom Jim O’Neill
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Pharma, Ecommerce, Manufacturing
  • Similar business models: B2C (Retail), B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Switzerland dRx Capital
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Manufacturing, Health services
  • Similar business models: B2C (Retail), B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States Justin Mateen
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Marketplace, Ecommerce, Manufacturing
  • Similar business models: B2C (Retail), B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States StartUp Health
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Ecommerce, Manufacturing, Health services
  • Similar business models: B2C (Retail), B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.1
  • Active last 12 months: Yes
Denmark Henrik Kraft
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Marketplace, Ecommerce, Health services
  • Similar business models: B2C (Retail), B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Sonder Capital
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Marketplace, Manufacturing, Health services
  • Similar business models: B2C (Retail), B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Canada Cross Border Impact Ventures
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Ecommerce, Manufacturing, Health services
  • Similar business models: B2C (Retail), B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
France Kamet Ventures
91%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Marketplace, Ecommerce, Health services
  • Similar business models: B2C (Retail), B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Top